Inactivated COVID-19 vaccine (Vero cells)

BIOLOGICAL2 trials

Sponsors

National Vaccine and Serum Institute, China

Conditions

COVID-19COVID-19 PneumoniaCoronavirus Infections

Phase 1

Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above

National Vaccine and Serum Institute, ChinaCoronavirus Infections, COVID-19 Pneumonia

Start: 2021-10-14End: 2024-02-29Target: 1848Updated: 2023-02-01

Phase 2

A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell)

National Vaccine and Serum Institute, ChinaCOVID-19

Start: 2022-05-25End: 2023-08-31Updated: 2023-02-02

Related Papers

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial

Nature Communications2022-06-2745 citations